Organic Process Research & Development 2004, 8, 666−669
An Efficient Synthesis of 2-Quinoxalinecarboxylic Acid
Arthur E. Harms*
Science and Technology Department, Albany Molecular Research, Inc., 21 Corporate Circle,
Albany, New York 12203, U.S.A.
Abstract:
tions, the hydrazone/osazone7 of a sugar is utilized. For
Development of a cost efficient and scaleable process for
2-quinoxalinecarboxylic acid is described. The primarily goals
of the development work were to improve the overall yield of
the process, to minimize the use of environmentally unaccept-
able materials, and to obtain a material with a high level of
purity. A variety of approaches were examined, and the most
efficient method was a condensation of o-phenylenediamine with
a monosaccharide followed by a mild peroxide oxidation.
example, fructose was converted to the fructose osazone/
hydrazone and condensed with o-phenylenediamine to
provide a moderate yield of the quinoxaline skeleton. While
some of these methods worked rather well, they required
materials that would be difficult to handle on large scale,
namely the hydrazine starting materials. In addition to the
handling of the toxic starting materials, large quantities of
the hydrazone would be present in the waste stream.
Results
In the development of an efficient route to 2-quinoxa-
linecarboxylic acid, we examined a number of different
approaches. One of the first routes investigated the straight-
forward approach of alkylating o-phenylenediamine with
ethyl 2,3-dibromopropanoate in the presence of triethylamine
(TEA, eq 1). Unfortunately, the reaction resulted in an
unacceptable yield of material that required a difficult
purification.
Introduction
The 2-substituted quinoxaline skeleton is a relatively
unexploited heterocycle in drug discovery. Only a few
examples of its use are found in the literature.1-3 The
synthesis of 2-quinoxalinecarboxylic acid has been reported
many times in the chemical literature, as early as 1935.4 Other
synthetic methods for the preparation of quinoxaline-
carboxylic acid include the oxidation of a nitroalkyl4 or
alkenyl5 substituent, usually with potassium permanga-
nate- or silver(I)-mediated hydrolysis of a tribromomethyl
side chain.7 Synthesis utilizing biocatalytic oxidation of
2-methylquinoxaline has also been described.8 A latent form
of carboxylic functionality is the 2-furyl group, which can
easily and quantitatively be cleaved by potassium perman-
ganate to yield the corresponding quinoxalinecarboxylic
acid.4 Another approach, which has had the most success,
involves the reaction of o-phenylenediamine with monosac-
charides9a-d followed by the oxidation of the resulting
condensed product.10,11 However, the yield of the condensa-
tion step has been poor (∼15-30%). In some other publica-
Deprotonation of quinoxaline with a variety of bases
(lithium diisopropylamide (LDA), potassium and lithium bis-
(trimethylsilyl)amide (KHMDS and LHMDS, respectively))
with subsequent quench using carbon dioxide failed to
provide any desired quinoxalinecarboxylic acid (eq 2). In a
similar approach, 2-chloroquinoxaline was submitted to
conditions of lithium-halogen exchange (eq 3). Under these
conditions, the starting material was consumed with no
detection of the desired quinoxalinecarboxylic acid.
* To whom correspondence should be addressed. E-mail: arthur.harms@
albmolecular.com.
(1) Seitz, L. E.; Suling, W. J.; Reynolds, R. C. J. Med. Chem. 2002, 45, 5604.
(2) Komatsu, M.; Sato, Hideaki, T.; Shinichi, M.; Masahiro, Magata, K.;
Yoshida, H.; Ueyama, A.; Nishi, T. Preparation of Quinoxaline-2-
Carboxamides as Antidiabetics. PCT Appl. WO 9509159 A1, April 6, 1995.
(3) Toshima, K.; Ohta, K.; Kano, T.; Nakamura, T.; Nakata, M.; Matsumura,
S. J. Chem. Soc., Chem. Commun. 1994, 19, 2295.
(4) Maurer, K.; Schiedt, B.; Schroeter, H. Chem. Ber. 1935, 68, 1716.
(5) Fanta P. E.; Stein, R. A.; Rickett, R. M. W. J. Am. Chem. Soc. 1958, 80,
4577.
(6) Keller-Scheirlien, W.; Prelog, V. HelV. Chim. Acta. 1957, 24, 205.
(7) Brown, B. R. J. Chem. Soc. 1949, 2577.
(8) Wong, J. N.; Watson, H., Jr.; Bouressa, J. F.; Burns, M. P.; Crawley, J. J.;
Doro, A. E.; Guzek, D. B.; Hintz, M. A.; McCormick, E. L.; Scully, D.
A.; Siderewicz, J. M.; Taylor, W. J.; Truesdale, S. J.; Wax, R. G. Org.
Process Res. DeV. 2002, 4, 477.
(9) (a) Griess, P.; Harrow, G. Chem. Ber. 1887, 20, 2205. (b) Hinsberg, O.
Chem. Ber. 1893, 26, 3092. (c) Ohle, H. Chem. Ber. 1934, 67, 155. (d)
Maurer, K.; Schiedt, B.; Schroeter, H.; Chem. Ber. 1935, 68, 1716.
(10) (a) Toldy et al. Acta Chim. Acad. Sci. Hung. 1954, 4, 303. (b) Muller, A.;
Varga, I. Chem. Ber. 1939, 72, 1993.
Another approach employing 2-chloroquinoxaline was to
displace the chloride with a nitrile. A neat mixture of
(11) Maurer, K.; Boettger, B. Chem. Ber. 1938, 71, 1183.
666
•
Vol. 8, No. 4, 2004 / Organic Process Research & Development
10.1021/op049951d CCC: $27.50 © 2004 American Chemical Society
Published on Web 06/16/2004